• 6-mo PFS rate: 61% in DP+C arm and 57% in DP arm. There were no significant differences in 6-mo OS rate, objective tumor and PSA response rates, and biomarkers in the two arms [261]. The gene discussed is KLK3; the disease is neoplasm.